Carly Kenselaar

Stock Analyst at Citigroup

(1.53)

# 2,378

Out of 4,433 analysts

3

Total ratings

50%

Success rate

18.66%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Upgrades: Buy	$7 → $10	$6.06	+65.02%	2	Dec 5, 2023
	KRYS Krystal Biotech	Initiates: Buy	$160	$164.10	-2.50%	1	Oct 12, 2023

Travere Therapeutics

Dec 5, 2023

Upgrades: Buy

Price Target: $7 → $10

Current: $6.06

Upside: +65.02%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $164.10

Upside: -2.50%